T1	Treatment 494 537	UGIE with sedation (0.1 mg/kg of midazolam)
T2	Treatment 542 727	without it (two endoscopies per volunteer in random order) were monitored throughout the procedure by means of electrocardiogram, blood pressure and peripheral oxygen saturation (SpO2).
T3	Treatment 728 879	Cardiac output was measured at six points before, during and after endoscopy from automated cardiac flow measurement by color Doppler echocardiography.
T4	Treatment 1588 1597	midazolam
